{"id":"https://openalex.org/W2899465706","doi":"https://doi.org/10.1007/s10549-018-5022-5","title":"Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer","display_name":"Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer","publication_year":2018,"publication_date":"2018-10-29","ids":{"openalex":"https://openalex.org/W2899465706","doi":"https://doi.org/10.1007/s10549-018-5022-5","mag":"2899465706","pmid":"https://pubmed.ncbi.nlm.nih.gov/30374681"},"language":"en","primary_location":{"id":"doi:10.1007/s10549-018-5022-5","doi":"https://doi.org/10.1007/s10549-018-5022-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10549-018-5022-5","pdf_url":null,"source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090686439","display_name":"Sonia Vallet","orcid":"https://orcid.org/0000-0003-0146-8089","observed_orcids":["https://orcid.org/0000-0003-0146-8089"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]},{"id":"https://openalex.org/I4210120342","display_name":"Universit\u00e4tsklinikum Krems","ror":"https://ror.org/02r2nns16","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210120342"]},{"id":"https://openalex.org/I4210149039","display_name":"Karl Landsteiner University of Health Sciences","ror":"https://ror.org/04t79ze18","country_code":"AT","type":"education","lineage":["https://openalex.org/I4210149039"]}],"countries":["AT","DE"],"is_corresponding":false,"raw_author_name":"Sonia Vallet","raw_affiliation_strings":["Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria","Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria","institution_ids":["https://openalex.org/I4210120342","https://openalex.org/I4210149039"]},{"raw_affiliation_string":"Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036422461","display_name":"Fengjuan Fan","orcid":"https://orcid.org/0000-0001-8727-5258","observed_orcids":["https://orcid.org/0000-0001-8727-5258"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]},{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN","DE"],"is_corresponding":false,"raw_author_name":"Fengjuan Fan","raw_affiliation_strings":["Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany","Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210111460"]},{"raw_affiliation_string":"Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060166280","display_name":"Stefano Malvestiti","orcid":"https://orcid.org/0000-0003-1595-2365","observed_orcids":["https://orcid.org/0000-0003-1595-2365"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stefano Malvestiti","raw_affiliation_strings":["Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111851690","display_name":"Martin Pecherstorfer","orcid":"https://orcid.org/0009-0009-8131-3909","observed_orcids":["https://orcid.org/0009-0009-8131-3909"]},"institutions":[{"id":"https://openalex.org/I4210120342","display_name":"Universit\u00e4tsklinikum Krems","ror":"https://ror.org/02r2nns16","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210120342"]},{"id":"https://openalex.org/I4210149039","display_name":"Karl Landsteiner University of Health Sciences","ror":"https://ror.org/04t79ze18","country_code":"AT","type":"education","lineage":["https://openalex.org/I4210149039"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Martin Pecherstorfer","raw_affiliation_strings":["Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria","institution_ids":["https://openalex.org/I4210120342","https://openalex.org/I4210149039"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034151974","display_name":"Martin Sattler","orcid":"https://orcid.org/0000-0001-5053-4199","observed_orcids":["https://orcid.org/0000-0001-5053-4199"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin Sattler","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","Department of Medicine, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089392438","display_name":"Andreas Schneewei\u00df","orcid":"https://orcid.org/0000-0002-2429-4512","observed_orcids":["https://orcid.org/0000-0002-2429-4512"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Schneeweiss","raw_affiliation_strings":["Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080906069","display_name":"Henning Schulze\u2010Bergkamen","orcid":"https://orcid.org/0000-0002-3227-5717","observed_orcids":["https://orcid.org/0000-0002-3227-5717"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Henning Schulze-Bergkamen","raw_affiliation_strings":["Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052507376","display_name":"Joseph T. Opferman","orcid":"https://orcid.org/0000-0002-1147-5621","observed_orcids":["https://orcid.org/0000-0002-1147-5621"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph T. Opferman","raw_affiliation_strings":["St. Jude Children's Research Hospital, Memphis, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Jude Children's Research Hospital, Memphis, TN, USA","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052090140","display_name":"Michael H. Cardone","orcid":"https://orcid.org/0000-0001-6484-5473","observed_orcids":["https://orcid.org/0000-0001-6484-5473","https://orcid.org/0009-0001-0356-7681"]},"institutions":[{"id":"https://openalex.org/I4210137507","display_name":"Eutropics Pharmaceuticals (United States)","ror":"https://ror.org/03kaqgs21","country_code":"US","type":"company","lineage":["https://openalex.org/I4210137507"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael H. Cardone","raw_affiliation_strings":["Eutropics Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eutropics Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210137507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113602946","display_name":"Dirk J\u00e4ger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dirk J\u00e4ger","raw_affiliation_strings":["Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany","German Cancer Research Center (DKFZ), Applied Tumor Immunity, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210111460"]},{"raw_affiliation_string":"German Cancer Research Center (DKFZ), Applied Tumor Immunity, Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007023688","display_name":"Klaus Podar","orcid":"https://orcid.org/0000-0002-7414-3632","observed_orcids":["https://orcid.org/0000-0002-7414-3632"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]},{"id":"https://openalex.org/I4210120342","display_name":"Universit\u00e4tsklinikum Krems","ror":"https://ror.org/02r2nns16","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210120342"]},{"id":"https://openalex.org/I4210149039","display_name":"Karl Landsteiner University of Health Sciences","ror":"https://ror.org/04t79ze18","country_code":"AT","type":"education","lineage":["https://openalex.org/I4210149039"]}],"countries":["AT","DE"],"is_corresponding":true,"raw_author_name":"Klaus Podar","raw_affiliation_strings":["Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria. klaus.podar@krems.lknoe.at","Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany. klaus.podar@krems.lknoe.at","Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria"],"raw_orcid":"https://orcid.org/0000-0002-7414-3632","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria. klaus.podar@krems.lknoe.at","institution_ids":["https://openalex.org/I4210120342","https://openalex.org/I4210149039"]},{"raw_affiliation_string":"Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany. klaus.podar@krems.lknoe.at","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210111460"]},{"raw_affiliation_string":"Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria","institution_ids":["https://openalex.org/I4210120342","https://openalex.org/I4210149039"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5007023688"],"corresponding_institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210111460","https://openalex.org/I4210120342","https://openalex.org/I4210149039"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":0.7934,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.68990646,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"173","issue":"3","first_page":"585","last_page":"596"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mcl-1-inhibitors","display_name":"Mcl-1 inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/bh3-mimetics","display_name":"BH3 mimetics","score":0.9240000247955322},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6000000238418579},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.7990000247955322},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.8309999704360962},{"id":"https://openalex.org/keywords/paclitaxel-resistance","display_name":"paclitaxel resistance","score":0.8339999914169312},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7870000004768372},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.8820000290870667},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9919999837875366},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.7210000157356262},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.5600000023841858},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.7250000238418579},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6826518177986145},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6499208807945251},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5569119453430176},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46874526143074036},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44778570532798767},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3966253697872162},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3874352276325226},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37890875339508057}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051020","descriptor_name":"bcl-X Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051020","descriptor_name":"bcl-X Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10549-018-5022-5","doi":"https://doi.org/10.1007/s10549-018-5022-5","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10549-018-5022-5","pdf_url":null,"source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},{"id":"pmid:30374681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30374681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast cancer research and treatment","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1489498714","https://openalex.org/W1964569316","https://openalex.org/W1982254984","https://openalex.org/W1983470364","https://openalex.org/W1986688227","https://openalex.org/W1990983360","https://openalex.org/W2008417818","https://openalex.org/W2024011783","https://openalex.org/W2024613683","https://openalex.org/W2024996523","https://openalex.org/W2027395744","https://openalex.org/W2030029504","https://openalex.org/W2038516046","https://openalex.org/W2046279786","https://openalex.org/W2048509801","https://openalex.org/W2059416155","https://openalex.org/W2059958613","https://openalex.org/W2060435066","https://openalex.org/W2064937772","https://openalex.org/W2068962767","https://openalex.org/W2069002336","https://openalex.org/W2069326426","https://openalex.org/W2080903411","https://openalex.org/W2082668371","https://openalex.org/W2085419794","https://openalex.org/W2088802752","https://openalex.org/W2094454542","https://openalex.org/W2095095520","https://openalex.org/W2096439168","https://openalex.org/W2110525250","https://openalex.org/W2116177527","https://openalex.org/W2117692326","https://openalex.org/W2123122199","https://openalex.org/W2123621979","https://openalex.org/W2134979684","https://openalex.org/W2136910701","https://openalex.org/W2138977668","https://openalex.org/W2150048195","https://openalex.org/W2153056550","https://openalex.org/W2161382947","https://openalex.org/W2168632005","https://openalex.org/W2275993376","https://openalex.org/W2534349779","https://openalex.org/W2563975158","https://openalex.org/W2741816049","https://openalex.org/W2743418290","https://openalex.org/W2766623255","https://openalex.org/W2783930641","https://openalex.org/W4250605151","https://openalex.org/W4301159569"],"related_works":["https://openalex.org/W2587205230","https://openalex.org/W2413183238","https://openalex.org/W2564417534","https://openalex.org/W2563975158","https://openalex.org/W4323570068","https://openalex.org/W1541769030","https://openalex.org/W4220834105","https://openalex.org/W1757608919","https://openalex.org/W2954063386","https://openalex.org/W1489498714"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-11-09T00:00:00"}